The Roslin Institute & R(D)SVS, University of Edinburgh, Easter Bush, Midlothian EH25 9RG, UK.
Guangzhou Institute of Cardiovascular Disease, Guangdong Key Laboratory of Vascular Diseases, State Key Laboratory of Respiratory Disease, the Second Affiliated Hospital, Guangzhou Medical University, Guangzhou 510260, China.
Int J Mol Sci. 2021 Apr 28;22(9):4620. doi: 10.3390/ijms22094620.
Sex differences in cardiovascular disease (CVD), including aortic stenosis, atherosclerosis and cardiovascular calcification, are well documented. High levels of testosterone, the primary male sex hormone, are associated with increased risk of cardiovascular calcification, whilst estrogen, the primary female sex hormone, is considered cardioprotective. Current understanding of sexual dimorphism in cardiovascular calcification is still very limited. This review assesses the evidence that the actions of sex hormones influence the development of cardiovascular calcification. We address the current question of whether sex hormones could play a role in the sexual dimorphism seen in cardiovascular calcification, by discussing potential mechanisms of actions of sex hormones and evidence in pre-clinical research. More advanced investigations and understanding of sex hormones in calcification could provide a better translational outcome for those suffering with cardiovascular calcification.
心血管疾病(CVD)中的性别差异,包括主动脉瓣狭窄、动脉粥样硬化和心血管钙化,已有充分的文献记载。高水平的睾酮,即主要的男性性激素,与心血管钙化风险增加有关,而雌激素,即主要的女性性激素,则被认为具有心脏保护作用。目前对心血管钙化中性别二态性的理解仍然非常有限。本综述评估了性激素作用影响心血管钙化发展的证据。我们通过讨论性激素作用的潜在机制以及临床前研究中的证据,探讨了性激素是否可能在心血管钙化中的性别二态性中发挥作用这一当前问题。对钙化过程中性激素的更深入研究和理解,可能会为那些患有心血管钙化的患者提供更好的转化治疗效果。